Shinichi Koizumi
Director/Board Member at TSUBOTA LABORATORY INCORPORATED
Shinichi Koizumi active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TSUBOTA LABORATORY INCORPORATED | Director/Board Member | 31/05/2020 | - |
| Independent Dir/Board Member | 31/05/2020 | - | |
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Director/Board Member | 31/12/2012 | - |
| Chief Tech/Sci/R&D Officer | 31/12/2012 | - | |
| Corporate Officer/Principal | 31/12/2012 | - |
Career history of Shinichi Koizumi
Former positions of Shinichi Koizumi
| Companies | Position | Start | End |
|---|---|---|---|
| RAQUALIA PHARMA INC. | Director/Board Member | 13/07/2011 | 31/07/2014 |
| Chief Tech/Sci/R&D Officer | 13/07/2011 | 28/11/2012 | |
| Corporate Officer/Principal | - | - |
Training of Shinichi Koizumi
| Tokyo Institute of Technology | Doctorate Degree |
Statistics
International
| Japan | 5 |
Operational
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| RAQUALIA PHARMA INC. | Health Technology |
| TSUBOTA LABORATORY INCORPORATED | Commercial Services |
| Private companies | 1 |
|---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
- Stock Market
- Insiders
- Shinichi Koizumi
- Experience